Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02318797 · ClinicalTrials.gov registry record · NA
Optimizing Behavioral Health Homes for Adults With Serious Mental Illness
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,229
- Enrollment target
NCT02318797: Completed NA study, sponsored by University of Pittsburgh.
NCT02318797 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,229 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (12% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02318797, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,229 participants
- Enrollment target
Study Summary
Adults with serious mental illness (SMI) frequently have unmet medical needs which place them at risk for adverse health outcomes. While there are proven ways to manage and/or prevent serious medical conditions common among this population, information is needed to understand their impact on outcomes that matter most for patients, particularly in community mental health centers (CMHCs) where most adults with SMI receive their care and rural areas where locating and receiving health care services can be challenging. The investigators will test two promising ways for promoting the health, wellness, and recovery of adults with SMI. One way will help patients manage their health and health care through self-management strategies, including the use of a web portal, and peer support (patient self-directed care) and the other through interactions with nurses during clinic visits (provider-supported integrated care). The investigators will compare the two interventions on three primary patient-centered outcomes (i.e. patient activation in care, health status, engagement in primary/specialty care). The investigators hypothesize that: 1. Patient self-directed care will result in improvement in patient activation. 2. Provider-supported integrated care will result in greater improvement in frequency in primary/specialty care visits. 3. Both interventions will result in significant improvements in the three primary outcomes. The investigators will collect information from patients, caregivers, and clinic staff at different points in time during the study. Patients will be asked to complete questionnaires and additional data on their service use will be gathered. Some patients and providers will also be interviewed about their experiences with care. The investigators will examine these data to learn if, how, and why the new services improve outcomes over time. This information will help us understand patient and other stakeholder views about the services and, if appropriate,
Primary Outcome
Assessed using the PAM, a 13-item scale that renders a total activation score. This measure gauges the knowledge, skills, and confidence of patients essential to managing their own health and health care. It divides into progressively higher levels of activation: starting to take a role, building knowledge and confidences, taking action, and maintaining behaviors. The raw score scale for the PAM ranges from 13 to 52. The activation scale for the PAM ranges from 0 to 100. The lower values represe
Interventions
- BEHAVIORAL Patient Self-Directed Care
- BEHAVIORAL Provider-Supported Integrated Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,229 participants |
| Start Date | 2013-10 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02318797 record still lists
NCT02318797 is an interventional study that assigns participants to a tested intervention. Its 1,229 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (12% lower).
The record links to 0 conditions, and to 2 interventions - of which Patient Self-Directed Care is the first listed.
NCT02318797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02318797 about?
NCT02318797 is a clinical study titled "Optimizing Behavioral Health Homes for Adults With Serious Mental Illness". Adults with serious mental illness (SMI) frequently have unmet medical needs which place them at risk for adverse health outcomes. While there are proven ways to manage and/or prevent serious medical conditions common among this population, information is needed to understand their impact on outcome...
What is the current status of trial NCT02318797?
This trial is currently completed. It is a NA study. The enrollment target is 1,229 participants. The study started on 2013-10. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02318797?
The interventions under investigation include: Patient Self-Directed Care (BEHAVIORAL), Provider-Supported Integrated Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT02318797?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02318797's enrollment target sits among peer trials
1,229 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia